SB 2205 creates a dedicated "charitable gaming operating fund" in North Dakota's state treasury to manage all taxes, fines, and penalties collected from charitable gaming activities (like bingo or raffles run by nonprofits). The bill requires quarterly allocations: $75,000 to the gambling disorder prevention and treatment fund, and 5% of total funds to cities and counties based on taxes collected from local games (with a minimum $200 threshold for payments). It also mandates that any excess funds remaining after covering administrative costs be transferred to the state's general fund every odd-numbered year. This bill directly affects how charitable gaming revenue is distributed to state programs and local governments.
HB 1154 extends a moratorium on adding new basic care and nursing facility bed capacity in North Dakota from August 1, 2023, through July 31, 2029. It prohibits new licenses for basic care beds unless facilities convert existing beds, demonstrate high demand (90% occupancy within 50 miles for 12 months), or receive department approval. The bill also restricts nursing facilities from changing bed configurations more than twice annually, except for specific conversions or relicensing after July 31, 2011. This law directly affects nursing homes and care facilities seeking to expand or reconfigure bed capacity across the state.
HB 1457 would create a new exemption allowing individuals to avoid required vaccines (for school, work, or licensing) if the vaccine doesn't meet specific safety and effectiveness standards. These standards require the FDA-approved vaccine to have undergone at least one year of safety testing against a placebo, with injury data publicly posted, a lower risk of serious harm than the disease itself, and manufacturer liability for deaths or injuries. The North Dakota Department of Health must publicize this exemption and prohibit state agencies from requiring conditions inconsistent with it. The bill failed to pass during its second reading in February 2025.
HB 1339 amends North Dakota law to clarify which licensed ambulance services are exempt from forming rural ambulance service districts. It specifically exempts county-owned, city-owned, jointly operated (with cities/counties), tribal/federal government-owned, hospital-owned, and existing rural ambulance service districts from these requirements. The bill directly affects local ambulance providers by removing a regulatory burden for these specific service types. This is a procedural change to existing code, not a new policy requiring public funding or service expansion.
HB 1337 would provide $10 million in state funds to counties for mental health and substance use disorder treatment services for people in jail. The bill requires counties receiving grants to report annually on how funds were used and outcomes, and the health department to submit a summary report to lawmakers by 2026. This funding would cover the 2025-2027 biennium and aim to expand access to mental health care for incarcerated individuals.
HB 1595 requires North Dakota pregnancy resource centers receiving state funding to meet specific health care and transparency standards. The bill mandates that funded centers must employ at least one licensed health care provider (like a nurse or physician), provide medically accurate and comprehensive pregnancy counseling, maintain HIPAA-compliant client records, and publish detailed organizational policies. Centers must also submit annual reports to the state including financial data, staff details, client service statistics (like pregnancy tests or ultrasounds provided), and material support given (e.g., diapers, baby supplies). These requirements apply directly to centers receiving state grants for pregnancy-related services. The bill was introduced in 2025 but failed to pass in committee.
Relating to public employee fertility health benefits; to provide for a report to the legislative assembly; to provide for application; and to provide an expiration date.
HB 1478, if enacted, would create new protections in North Dakota law for access to contraceptives. It defines contraceptives broadly (including pills, IUDs, condoms, and patches) while excluding abortion drugs, and guarantees individuals the right to receive, purchase, or use contraception under evidence-based medical guidelines. The bill also protects health care providers who decline to provide contraception based on religious or moral objections, and ensures health insurers cover contraceptive care. It allows lawsuits against state entities that restrict these rights, with penalties including court-ordered relief and attorney fees for successful plaintiffs.
HB 1451 would require North Dakota's medical assistance program (including Medicaid) to cover comprehensive obesity treatment, such as intensive behavioral therapy, bariatric surgery, and FDA-approved antiobesity medications. The bill mandates that coverage criteria for antiobesity medication align with FDA approvals and prohibits separate cost-sharing (like higher deductibles or copays) for obesity treatment compared to other medical conditions. It also requires the state to provide written notice to enrollees about this coverage by December 31, 2025. This bill directly affects Medicaid enrollees in North Dakota seeking obesity-related treatments.
HB 1477 would create new legal protections for fertility care access in North Dakota. It guarantees individuals the right to receive fertility treatments and make decisions about reproductive genetic material, while also protecting health care providers, insurers, and manufacturers from state restrictions on these services. The bill prohibits state agencies or subdivisions from implementing policies that limit access to fertility treatments, except for health/safety regulations that follow established medical guidelines. Violations could trigger civil lawsuits by affected individuals or the attorney general, with courts able to block the restrictive policy and award legal fees to the winning party. This bill directly affects patients seeking fertility care, clinics providing those services, health insurers, and manufacturers of fertility-related products.
